Another Ebola Vaccine Among New Filings At EMA
Four New EU Marketing Applications Granted Fast-Track Status
The European Medicines Agency has received 11 new marketing authorization applications, including three for orphan products from Vertex, MYR Pharmaceuticals and AstraZeneca.
